✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (231 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
40.58
4,42,893
65.25
1,48,241
25.26
1,06,010
22.96
1,04,366
19.26
1,02,691
55.16
98,148
18.96
93,655
24.80
86,461
27.74
65,775
169
65,185
59.76
63,652
36.83
57,157
40.62
41,472
36.57
38,617
42.16
38,359
48.29
34,260
33.98
31,413
119
25,528
29.95
21,634
13.59
21,165
1,045
21,020
103
20,771
43.55
18,804
30.32
18,038
48.63
16,908
24.01
15,103
22.42
13,760
31.71
12,720
93.92
12,619
37.74
11,795
20.77
10,622
40.88
10,544
50.36
10,424
53.76
9,952
122
9,388
24.98
9,000
57.09
8,566
28.86
8,471
26.12
8,310
24.04
7,449
51.71
7,171
28.21
6,113
-
5,677
-
5,413
35.26
4,969
-
4,185
24.54
4,140
82.58
3,946
33.24
3,828
41.93
3,756
190
3,590
16.80
3,403
33.44
3,397
26.77
3,103
59.70
2,987
26.46
2,886
8.70
2,565
23.65
2,352
7.28
2,322
-
2,235
146
2,082
-
1,999
30.75
1,739
24.39
1,628
27.76
1,608
35.23
1,442
33.14
1,428
38.67
1,357
15.23
1,337
60.38
1,331
39.83
1,302
18.54
1,278
21.14
1,270
41.58
1,267
16.28
1,242
4.82
1,197
48.25
1,118
25.18
1,068
24.10
1,057
46.35
988
-
893
44.08
884
20.35
875
-
855
9.59
842
19.29
807
43.71
723
34.79
714
30.11
702
48.50
648
35.25
637
79.40
554
49.64
521
19.95
520
14.81
515
25.48
513
25.45
504
-
443
19.72
391
39.54
373
43.70
351
29.94
347
37.06
335
34.18
330
66.77
328
16.92
322
66.74
308
-
292
-
287
-
275
24.26
258
-
251
25.45
250
29.07
250
71.85
247
29.98
246
42.05
245
13.61
240
21.52
237
-
220
20.59
215
-
204
30.65
204
39.24
199
22.27
184
14.67
184
38.14
183
13.31
181
33.42
179
660
171
-
171
56.44
167
17.40
167
6.77
164
636
160
34.91
157
11.02
154
12.45
153
17.46
150
6.79
147
12.47
145
20.51
138
14.06
136
27.57
133
28.39
130
15.91
129
34.44
127
-
125
15.32
123
17.48
107
189
107
-
106
12.02
105
26.25
98
77.28
94
-
93
19.21
91
115
85
27.72
77
-
75
-
71
6.47
69
15.55
67
9.34
67
-
65
3.62
64
14.37
62
13.53
61
12.02
60
138
55
12.93
54
-
54
7.49
54
19.39
54
15.56
52
19.90
50
-
49
-
49
210
47
-
46
55.52
44
18.38
43
21.55
42
94.92
42
51.79
39
-
38
35.51
37
23.94
37
-
36
-
34
7.85
33
-
32
13.35
30
6.29
30
32.22
28
332
28
-
27
6.32
26
11.61
25
7.14
24
27.79
24
26.94
24
10.69
22
-
21
-
21
-
17
37.09
17
23.52
15
51.21
15
-
14
29.58
13
12.96
13
91.40
12
-
12
23.60
12
-
12
-
12
799
10
8.21
9
64.30
9
89.76
7
824
7
-
7
-
7
-
6
-
6
-
5
44.38
5
69.81
4
-
3
-
2
Showing 5 231 of 231 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material